Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Jun;85(6):1974–1982. doi: 10.1172/JCI114661

Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.

K Takahashi 1, G F Schreiner 1, K Yamashita 1, B W Christman 1, I Blair 1, K F Badr 1
PMCID: PMC296666  PMID: 2347921

Abstract

While much is known regarding acute nephrotoxic serum (NTS)-induced glomerular injury, the glomerular dynamics and pathophysiologic mediators of the more relevant chronic autologous phase remain poorly defined. Studies were performed in rats 14 d after injection of rabbit serum (n = 6), NTS in the absence (n = 6), or presence, of a cyclooxygenase inhibitor, ibuprofen (n = 6) or a thromboxane A2 (TxA2) receptor antagonist, L-670,596 (n = 5). A mesangial macrophage/monocyte infiltrate was noted with equal intensity in all NTS-treated rats. Glomerular generation rates of prostaglandin (PG) E2, PGF2a, and TxA2 in nephritic kidneys were dramatically increased as compared to controls. 2 wk after NTS, there was an increase in glomerular plasma flow rate (SNPF), attainment of filtration pressure disequilibrium, and augmentation of net transcapillary hydraulic pressure difference (delta P). Glomerular filtration rate (GFR), however, was reduced, due to a marked fall in the glomerular capillary ultrafiltration coefficient (Kf). Cyclooxygenase inhibition resulted in normalization of glomerular eicosanoid generation rates, amelioration of proteinuria, afferent vasoconstriction, and normalization of SNPF, delta P, Kf, and GFR. Selective antagonism of TxA2 also led to preservation of Kf, but was without effect on SNPF, thereby leading to elevated values for GFR. Thus, in contrast to the pathophysiologic role of arachidonate-lipoxygenase products in the early heterologous phase, PG-mediated vasodilatation and TxA2-induced reductions in Kf and GFR underlie glomerular functional changes during autologous mesangioproliferative glomerulonephritis.

Full text

PDF
1974

Images in this article

1977Image
on p.1977
1977Image
on p.1977
1977Image
on p.1977
1977Image
on p.1977
1978Image
on p.1978
1978Image
on p.1978
1979Image
on p.1979
1979Image
on p.1979

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. E., Wilson C. B., Gottschalk C. W. Pathophysiology of experimental glomerulonephritis in rats. J Clin Invest. 1974 May;53(5):1402–1423. doi: 10.1172/JCI107689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Badr K. F., Brenner B. M., Ichikawa I. Effects of leukotriene D4 on glomerular dynamics in the rat. Am J Physiol. 1987 Aug;253(2 Pt 2):F239–F243. doi: 10.1152/ajprenal.1987.253.2.F239. [DOI] [PubMed] [Google Scholar]
  4. Badr K. F., DeBoer D. K., Takahashi K., Harris R. C., Fogo A., Jacobson H. R. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. Am J Physiol. 1989 Jan;256(1 Pt 2):F35–F43. doi: 10.1152/ajprenal.1989.256.1.F35. [DOI] [PubMed] [Google Scholar]
  5. Badr K. F., Schreiner G. F., Wasserman M., Ichikawa I. Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest. 1988 Jun;81(6):1702–1709. doi: 10.1172/JCI113509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baylis C., Brenner B. M. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res. 1978 Dec;43(6):889–898. doi: 10.1161/01.res.43.6.889. [DOI] [PubMed] [Google Scholar]
  7. Bertani T., Livio M., Macconi D., Morigi M., Bisogno G., Patrono C., Remuzzi G. Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis. Kidney Int. 1987 Jun;31(6):1248–1256. doi: 10.1038/ki.1987.138. [DOI] [PubMed] [Google Scholar]
  8. Blantz R. C., Konnen K. S., Tucker B. J. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest. 1976 Feb;57(2):419–434. doi: 10.1172/JCI108293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Blantz R. C., Tucker B. J., Gushwa L. C., Peterson O. W., Wilson C. B. Glomerular immune injury in the rat: the influence of angiotensin II and alpha-adrenergic inhibitors. Kidney Int. 1981 Oct;20(4):452–461. doi: 10.1038/ki.1981.161. [DOI] [PubMed] [Google Scholar]
  10. Blantz R. C., Wilson C. B. Acute effects of antiglomerular basement membrane antibody on the process of glomerular filtration in the rat. J Clin Invest. 1976 Oct;58(4):899–911. doi: 10.1172/JCI108543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bohrer M. P., Deen W. M., Robertson C. R., Brenner B. M. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol. 1977 Jul;233(1):F13–F21. doi: 10.1152/ajprenal.1977.233.1.F13. [DOI] [PubMed] [Google Scholar]
  12. Christman B. W., Blair I. A. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom. 1989 Apr;18(4):258–264. doi: 10.1002/bms.1200180409. [DOI] [PubMed] [Google Scholar]
  13. Deen W. M., Troy J. L., Robertson C. R., Brenner B. M. Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest. 1973 Jun;52(6):1500–1508. doi: 10.1172/JCI107324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dijkstra C. D., Döpp E. A., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985 Mar;54(3):589–599. [PMC free article] [PubMed] [Google Scholar]
  15. Ford-Hutchinson A. W., Girard Y., Lord A., Jones T. R., Cirino M., Evans J. F., Gillard J., Hamel P., Leveillé C., Masson P. The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Can J Physiol Pharmacol. 1989 Sep;67(9):989–993. doi: 10.1139/y89-155. [DOI] [PubMed] [Google Scholar]
  16. Friedman S., Strober S., Field E. H., Silverman E., Myers B. D. Glomerular capillary wall function in human lupus nephritis. Am J Physiol. 1984 May;246(5 Pt 2):F580–F591. doi: 10.1152/ajprenal.1984.246.5.F580. [DOI] [PubMed] [Google Scholar]
  17. Kaizu K., Marsh D., Zipser R., Glassock R. J. Role of prostaglandins and angiotensin II in experimental glomerulonephritis. Kidney Int. 1985 Oct;28(4):629–635. doi: 10.1038/ki.1985.175. [DOI] [PubMed] [Google Scholar]
  18. Kreisberg J. I., Wayne D. B., Karnovsky M. J. Rapid and focal loss of negative charge associated with mononuclear cell infiltration early in nephrotoxic serum nephritis. Kidney Int. 1979 Sep;16(3):290–300. doi: 10.1038/ki.1979.131. [DOI] [PubMed] [Google Scholar]
  19. Lefkowith J. B., Schreiner G. Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest. 1987 Oct;80(4):947–956. doi: 10.1172/JCI113187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lianos E. A., Andres G. A., Dunn M. J. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest. 1983 Oct;72(4):1439–1448. doi: 10.1172/JCI111100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lianos E. A., Rahman M. A., Dunn M. J. Glomerular arachidonate lipoxygenation in rat nephrotoxic serum nephritis. J Clin Invest. 1985 Oct;76(4):1355–1359. doi: 10.1172/JCI112110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lianos E. A. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles. J Clin Invest. 1988 Aug;82(2):427–435. doi: 10.1172/JCI113615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maddox D. A., Bennett C. M., Deen W. M., Glassock R. J., Knutson D., Daugharty T. M., Brenner B. M. Determinants of glomerular filtration in experimental glomerulonephritis in the rat. J Clin Invest. 1975 Feb;55(2):305–318. doi: 10.1172/JCI107934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Maddox D. A., Price D. C., Rector F. C., Jr Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol. 1977 Dec;233(6):F600–F606. doi: 10.1152/ajprenal.1977.233.6.F600. [DOI] [PubMed] [Google Scholar]
  25. Myers B. D., Okarma T. B., Friedman S., Bridges C., Ross J., Asseff S., Deen W. M. Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest. 1982 Oct;70(4):732–746. doi: 10.1172/JCI110669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pierucci A., Simonetti B. M., Pecci G., Mavrikakis G., Feriozzi S., Cinotti G. A., Patrignani P., Ciabattoni G., Patrono C. Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N Engl J Med. 1989 Feb 16;320(7):421–425. doi: 10.1056/NEJM198902163200703. [DOI] [PubMed] [Google Scholar]
  27. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. doi: 10.1016/0090-6980(80)90144-6. [DOI] [PubMed] [Google Scholar]
  28. Rahman M. A., Nakazawa M., Emancipator S. N., Dunn M. J. Increased leukotriene B4 synthesis in immune injured rat glomeruli. J Clin Invest. 1988 Jun;81(6):1945–1952. doi: 10.1172/JCI113542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Roszinski S., Jelkmann W. Effect of PO2 on prostaglandin E2 production in renal cell cultures. Respir Physiol. 1987 Nov;70(2):131–141. doi: 10.1016/0034-5687(87)90045-4. [DOI] [PubMed] [Google Scholar]
  30. Sakai T., Harris F. H., Jr, Marsh D. J., Bennett C. M., Glassock R. J. Extracellular fluid expansion and autoregulation in nephrotoxic serum nephritis in rats. Kidney Int. 1984 Apr;25(4):619–628. doi: 10.1038/ki.1984.66. [DOI] [PubMed] [Google Scholar]
  31. Scharschmidt L. A., Douglas J. G., Dunn M. J. Angiotensin II and eicosanoids in the control of glomerular size in the rat and human. Am J Physiol. 1986 Feb;250(2 Pt 2):F348–F356. doi: 10.1152/ajprenal.1986.250.2.F348. [DOI] [PubMed] [Google Scholar]
  32. Schlondorff D., Ardaillou R. Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int. 1986 Jan;29(1):108–119. doi: 10.1038/ki.1986.13. [DOI] [PubMed] [Google Scholar]
  33. Schreiner G. F., Cotran R. S., Pardo V., Unanue E. R. A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med. 1978 Feb 1;147(2):369–384. doi: 10.1084/jem.147.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schreiner G. F., Cotran R. S., Unanue E. R. Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest. 1984 Nov;51(5):524–533. [PubMed] [Google Scholar]
  35. Schreiner G. F., Kiely J. M., Cotran R. S., Unanue E. R. Characterization of resident glomerular cells in the rat expressing Ia determinants and manifesting genetically restricted interactions with lymphocytes. J Clin Invest. 1981 Oct;68(4):920–931. doi: 10.1172/JCI110347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Smith H. W., Finkelstein N., Aliminosa L., Crawford B., Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945 May;24(3):388–404. doi: 10.1172/JCI101618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Stork J. E., Dunn M. J. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. J Pharmacol Exp Ther. 1985 Jun;233(3):672–678. [PubMed] [Google Scholar]
  38. Tucker B. J., Gushwa L. C., Wilson C. B., Blantz R. C. Effect of leukocyte depletion on glomerular dynamics during acute glomerular immune injury. Kidney Int. 1985 Jul;28(1):28–35. doi: 10.1038/ki.1985.114. [DOI] [PubMed] [Google Scholar]
  39. Unanue E. R., Dixon F. J. Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol. 1967;6:1–90. doi: 10.1016/s0065-2776(08)60521-0. [DOI] [PubMed] [Google Scholar]
  40. Viets J. W., Deen W. M., Troy J. L., Brenner B. M. Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem. 1978 Aug 1;88(2):513–521. doi: 10.1016/0003-2697(78)90451-7. [DOI] [PubMed] [Google Scholar]
  41. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  42. Yoshioka T., Mitarai T., Kon V., Deen W. M., Rennke H. G., Ichikawa I. Role for angiotensin II in an overt functional proteinuria. Kidney Int. 1986 Oct;30(4):538–545. doi: 10.1038/ki.1986.219. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES